BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38613582)

  • 1. The impact of the COVID-19 pandemic on renal cancer care.
    Yildirim H; Bins AD; van den Hurk C; van Moorselaar RJA; van Oijen MGH; Bex A; Zondervan PJ; Aben KKH
    World J Urol; 2024 Apr; 42(1):231. PubMed ID: 38613582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.
    Zequi SC; Abreu D
    Int Braz J Urol; 2020 Jul; 46(suppl.1):69-78. PubMed ID: 32549075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data.
    Guðmundsson E; Hellborg H; Lundstam S; Erikson S; Ljungberg B;
    Eur Urol; 2011 Nov; 60(5):975-82. PubMed ID: 21741160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.
    Chan VW; Tan WS; Leow JJ; Tan WP; Ong WLK; Chiu PK; Gurung P; Pirola GM; Orecchia L; Liew MPC; Lee HY; Wang Y; Chen IA; Castellani D; Wroclawski ML; Mayor N; Sathianathen NJ; Braga I; Liu Z; Moon D; Tikkinen K; Kamat A; Meng M; Ficarra V; Giannarini G; Teoh JY
    World J Urol; 2021 Dec; 39(12):4295-4303. PubMed ID: 34031748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
    Srivastava A; Patel HV; Kim S; Shinder B; Sterling J; Tabakin AL; Polotti CF; Saraiya B; Mayer T; Kim IY; Ghodoussipour S; Patel HD; Jang TL; Singer EA
    Urol Oncol; 2021 May; 39(5):247-257. PubMed ID: 33223368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal cell carcinoma diagnosed at autopsy in Iceland 1971-2005].
    Jonsson A; Hardarson S; Petursdottir V; Palsdottir HB; Jonsson E; Einarsson GV; Gudbjartsson T
    Laeknabladid; 2008 Dec; 94(12):807-12. PubMed ID: 19182316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma in South Korea: a multicenter study.
    Kim H; Cho NH; Kim DS; Kwon YM; Kim EK; Rha SH; Park YW; Shim JW; Lee SS; Lee SN; Lee J; Lee JS; Lee TJ; Jung SJ; Jung SH; Chung JH; Cho HY; Joo HJ; Choi YJ; Choi C; Han WS; Hur B; Ro JY;
    Hum Pathol; 2004 Dec; 35(12):1556-63. PubMed ID: 15619217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
    Mokos M; Bašić-Jukić N
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic and clinical characteristics of early onset renal cell carcinoma.
    Clemmensen T; Matoso A; Graham T; Lai WS; Rais-Bahrami S; Gordetsky J
    Hum Pathol; 2018 Apr; 74():25-31. PubMed ID: 29133143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CCAFU Recommendations 2013: Renal cancer].
    Patard JJ; Baumert H; Bensalah K; Bernhard JC; Bigot P; Escudier B; Grenier N; Hétet JF; Long JA; Méjean A; Paparel P; Richard S; Rioux-Leclercq N; Coloby P; Soulié M;
    Prog Urol; 2013 Nov; 23 Suppl 2():S177-204. PubMed ID: 24485292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
    Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
    Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.
    Patel HD; Kates M; Pierorazio PM; Allaf ME
    Urol Oncol; 2014 Jul; 32(5):576-83. PubMed ID: 24629500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare patients in routine care: Treatment and outcome in advanced papillary renal cell carcinoma in the prospective German clinical RCC-Registry.
    Staehler M; Goebell PJ; Müller L; Emde TO; Wetzel N; Kruggel L; Jänicke M; Marschner N;
    Int J Cancer; 2020 Mar; 146(5):1307-1315. PubMed ID: 31498894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
    Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
    Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better survival of renal cell carcinoma in patients with inflammatory bowel disease.
    Derikx LA; Nissen LH; Drenth JP; van Herpen CM; Kievit W; Verhoeven RH; Mulders PF; Hulsbergen-van de Kaa CA; Boers-Sonderen MJ; van den Heuvel TR; Pierik M; Nagtegaal ID; Hoentjen F; ; ;
    Oncotarget; 2015 Nov; 6(35):38336-47. PubMed ID: 26447542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
    Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
    Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
    Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.